Monday, December 23, 2024
HomeTagsSelective mTOR Inhibitors

Selective mTOR Inhibitors

Cambrian Biopharma Announces Licensing Agreement to Develop Selective mTOR Inhibitors

Cambrian Biopharma, a multi-asset longevity biotech, announced a licensing agreement with Novartis to advance novel, selective compounds designed and characterized by Novartis to target...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics